Cytolytic T Cell Activity In Response To Primary RSV Infection In Mice
Cytolytic T Cell Activity In Response To Primary RSV Infection In Mice
批准号:
8745619
负责人:
Barney Graham
金额:
$64.55万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AdultAntiviral AgentsAvidityCD4 Positive T LymphocytesCD8B1 geneCellsCharacteristicsChildCytopathologyCytotoxic T-LymphocytesDendritic CellsDevelopmentDiseaseEpitopesIL2RA geneImmune responseImmunizationInfantInfectionLifeLower Respiratory Tract InfectionLungMediatingMusNeonatalPopulationPropertyRegulatory T-LymphocyteRespiratory Syncytial Virus InfectionsRespiratory syncytial virusSatellite VirusesT cell responseT-LymphocyteTransgenic MiceViralVirusWorkage relatedcell typedefined contributionimmunopathologylymph nodesresponse
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract infections in infants and small children. RSV infection in mice is characterized by significant immunopathology which is mediated by CD8+ cytotoxic T lymphocytes (CTL). Past studies have suggested that CD8+ T cells with different functional properties and characteristics can be elicited following infection or immunization, and may have differential effects on viral clearance and RSV-associated illness. We have described differences between neonatal and adult CD8+ T cell responses elicited during RSV infection. Differences in clonotype, functional avidity, and other intrinsic parameters of the CD8+ T cell response may help dictate the epitope hierarchy established following infection. We have now defined the dynamics of lung-migratory dendritic cell populations in the lung and lung-draining lymph nodes of RSV-infected mice during early life as compared to adulthood and have determined lung dendritic cell populations that induce RSV-specific adaptive T cell responses following infection. These dendritic cells were found to induce T cell responses in an age-dependent manner, and we have implicated lower costimulatory molecule expression by neonatal dendritic cells as one mechanism for this difference. Our work in the last year has been greatly aided by the development and characterization of three strains of transgenic mice with CD8+ T cells specific for RSV. Continued work on this study will fully characterize CD8+ T responses to RSV, elucidate important factors that dictate the type of CD8+ T cell response that is generated, and help understand how other cell types regulate the CD8+ T cell response in an age-dependent fashion.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cellular Immune Responses to RSV infection in Mice
-
批准号:10273005
-
项目类别:
-
资助金额:$65.4万
-
财政年份:--
-
负责人:Barney Graham
-
依托单位:
Rapid Development of Vaccines for Emerging Viruses
-
批准号:10497747
-
项目类别:
-
资助金额:$160.49万
-
财政年份:--
-
负责人:Barney Graham
-
依托单位:
Coronavirus vaccine development
-
批准号:9551285
-
项目类别:
-
资助金额:$84.1万
-
财政年份:--
-
负责人:Barney Graham
-
依托单位:
Factors Contributing To Immune-Enhanced Disease In The Pathogenesis of RSV
-
批准号:7964834
-
项目类别:
-
资助金额:$100.68万
-
财政年份:--
-
负责人:Barney Graham
-
依托单位:
Vectors and Methods to Increase Immunogenicity during DNA Vaccination
-
批准号:7964850
-
项目类别:
-
资助金额:$26.73万
-
财政年份:--
-
负责人:Barney Graham
-
依托单位:
HIV Preventive Vaccine Studies
-
批准号:7964840
-
项目类别:
-
资助金额:$178.57万
-
财政年份:--
-
负责人:Barney Graham
-
依托单位:
Vaccine Studies in HIV-infected Subjects
-
批准号:8148436
-
项目类别:
-
资助金额:$55.53万
-
财政年份:--
-
负责人:Barney Graham
-
依托单位:
HIV Preventive Vaccine Studies
-
批准号:8148433
-
项目类别:
-
资助金额:$412.21万
-
财政年份:--
-
负责人:Barney Graham
-
依托单位:
Factors Contributing To Immune-Enhanced Disease In The Pathogenesis of RSV
-
批准号:8336383
-
项目类别:
-
资助金额:$62.36万
-
财政年份:--
-
负责人:Barney Graham
-
依托单位:
Cytolytic T Cell Activity In Response To Primary RSV Infection In Mice
-
批准号:8556100
-
项目类别:
-
资助金额:$68.67万
-
财政年份:--
-
负责人:Barney Graham
-
依托单位:
HIV Preventive Vaccine and Monoclonal Antibody Studies
-
批准号:8745624
-
项目类别:
-
资助金额:$556.21万
-
财政年份:--
-
负责人:Barney Graham
-
依托单位:
Sample Collection and General Screening Protocols
-
批准号:8745625
-
项目类别:
-
资助金额:$50.97万
-
财政年份:--
-
负责人:Barney Graham
-
依托单位:
Antigenicity and Immunogenicity of Stabilized prefusion F protein
-
批准号:9551287
-
项目类别:
-
资助金额:$111.33万
-
财政年份:--
-
负责人:Barney Graham
-
依托单位:
Clinical Trial Infrastructure Support - Data/Enrollee Management
-
批准号:7732790
-
项目类别:
-
资助金额:$230.49万
-
财政年份:--
-
负责人:Barney Graham
-
依托单位:
Influenza Vaccine Development
-
批准号:10018361
-
项目类别:
-
资助金额:$380.61万
-
财政年份:--
-
负责人:Barney Graham
-
依托单位:
Antigenicity and Immunogenicity of Stabilized prefusion F protein
-
批准号:10018380
-
项目类别:
-
资助金额:$190.3万
-
财政年份:--
-
负责人:Barney Graham
-
依托单位:
Cytolytic T Cell Activity In Response To Primary RSV Infection In Mice
-
批准号:8148428
-
项目类别:
-
资助金额:$94.01万
-
财政年份:--
-
负责人:Barney Graham
-
依托单位:
Antigenicity and Immunogenicity of Stabilized prefusion F protein
-
批准号:10273020
-
项目类别:
-
资助金额:$130.91万
-
财政年份:--
-
负责人:Barney Graham
-
依托单位:
Coronavirus vaccine development
-
批准号:10497745
-
项目类别:
-
资助金额:$52.25万
-
财政年份:--
-
负责人:Barney Graham
-
依托单位:
Antigenicity and Immunogenicity of Stabilized prefusion F protein
-
批准号:10497748
-
项目类别:
-
资助金额:$144.73万
-
财政年份:--
-
负责人:Barney Graham
-
依托单位:
海外基金